Antibody data
- Antibody Data
- Antigen structure
- References [13]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16025-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16025-1-AP, RRID:AB_10916385
- Product name
- CST1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CST1 antibody (Cat. #16025-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Validation of serum cystatin SN detection for diagnosis and poor prognosis of esophageal squamous cell carcinoma.
TFAP2C Activates CST1 Transcription to Facilitate Breast Cancer Progression and Suppress Ferroptosis.
SPI1-Mediated Upregulation of the CST1 Gene as an Independent Poor Prognostic Factor Accelerates Metastasis in Esophageal Squamous Cell Carcinoma (ESCC) by Interacting with MMP2.
Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application.
CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1.
Cancer-associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T-cell suppression.
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules.
An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma.
Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism.
Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment.
Proteomic profiling of human decidual immune proteins during Toxoplasma gondii infection.
Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.
Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.
Pi Y, Lin S, Ren X, Wang L, Song Y, Wu Z, Lai Y
Frontiers in oncology 2024;14:1337707
Frontiers in oncology 2024;14:1337707
TFAP2C Activates CST1 Transcription to Facilitate Breast Cancer Progression and Suppress Ferroptosis.
Yuan L, Zhou D, Li W, Guan J, Li J, Xu B
Biochemical genetics 2024 Oct;62(5):3858-3875
Biochemical genetics 2024 Oct;62(5):3858-3875
SPI1-Mediated Upregulation of the CST1 Gene as an Independent Poor Prognostic Factor Accelerates Metastasis in Esophageal Squamous Cell Carcinoma (ESCC) by Interacting with MMP2.
Luo FF, Wang J, Zhang ZF, Lin ST, Huang TJ, Liu BQ, Fan ML, Peng LX, Zheng ST, Yang CF, Huang BJ
Frontiers in bioscience (Landmark edition) 2023 Sep 24;28(9):212
Frontiers in bioscience (Landmark edition) 2023 Sep 24;28(9):212
Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application.
Ren X, Huang M, Weng W, Xie Y, Wu Y, Zhu S, Zhang Y, Li D, Lai J, Shen S, Lin J, Kuang M, Li X, Yu J, Xu L
Cell reports. Medicine 2023 Nov 21;4(11):101277
Cell reports. Medicine 2023 Nov 21;4(11):101277
CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1.
Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, Li W, Shu G, Yang J, Shen W, Qin L, Hu L, Zhou J
Oncogene 2023 Jan;42(2):83-98
Oncogene 2023 Jan;42(2):83-98
Cancer-associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T-cell suppression.
Itoh G, Takagane K, Fukushi Y, Kuriyama S, Umakoshi M, Goto A, Yanagihara K, Yashiro M, Tanaka M
Molecular oncology 2022 Jan;16(1):166-187
Molecular oncology 2022 Jan;16(1):166-187
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules.
Lai Y, Wang Y, Wu Y, Wu M, Xing S, Xie Y, Chen S, Li X, Zhang A, He Y, Li H, Dai S, Wang J, Lin S, Bai Y, Du H, Liu W
Cancer control : journal of the Moffitt Cancer Center 2022 Jan-Dec;29:10732748221104661
Cancer control : journal of the Moffitt Cancer Center 2022 Jan-Dec;29:10732748221104661
An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma.
Zhang H, Shi Q, Yang Z, Wang K, Zhang Z, Huang Z, Cui X, Li F
Frontiers in molecular biosciences 2021;8:598427
Frontiers in molecular biosciences 2021;8:598427
Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism.
Han J, Zhao Z, Zhang N, Yang Y, Ma L, Feng L, Zhang X, Zuo J, Fan Z, Wang Y, Song Y, Wang G
Aging 2021 Jan 20;13(4):5034-5054
Aging 2021 Jan 20;13(4):5034-5054
Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment.
Dinh HQ, Pan F, Wang G, Huang QF, Olingy CE, Wu ZY, Wang SH, Xu X, Xu XE, He JZ, Yang Q, Orsulic S, Haro M, Li LY, Huang GW, Breunig JJ, Koeffler HP, Hedrick CC, Xu LY, Lin DC, Li EM
Nature communications 2021 Dec 17;12(1):7335
Nature communications 2021 Dec 17;12(1):7335
Proteomic profiling of human decidual immune proteins during Toxoplasma gondii infection.
Zhang D, Sun X, Ren L, Yang C, Liu X, Zhang H, Jiang Y, Hu X
Journal of proteomics 2018 Aug 30;186:28-37
Journal of proteomics 2018 Aug 30;186:28-37
Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.
Dai DN, Li Y, Chen B, Du Y, Li SB, Lu SX, Zhao ZP, Zhou AJ, Xue N, Xia TL, Zeng MS, Zhong Q, Wei WD
Journal of molecular medicine (Berlin, Germany) 2017 Aug;95(8):873-886
Journal of molecular medicine (Berlin, Germany) 2017 Aug;95(8):873-886
Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.
Jin L, Zhang Y, Li H, Yao L, Fu D, Yao X, Xu LX, Hu X, Hu G
Cell research 2012 Sep;22(9):1356-73
Cell research 2012 Sep;22(9):1356-73
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CST1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CST1. This antibody recognizes human antigen. The CST1 antibody has been validated for the following applications: ELISA, WB analysis.